Pulmonary arterial size and response to sildenafil in chronic thromboembolic pulmonary hypertension

Journal of Heart and Lung Transplantation

Volumn 29, Issue 6, 2010, Pages 610-615

  Toshner, Mark R ^a,b   Gopalan, Deepa ^b   Suntharalingam, Jay ^c   Treacy, Carmen ^b   Soon, Elaine ^b   Sheares, Karen K ^b   Morrell, Nicholas W ^a   Screaton, Nicholas ^b   Pepke Zaba, Joanna ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b PAPWORTH HOSPITAL   (United Kingdom)

^c ROYAL UNITED HOSPITAL   (United Kingdom)

Author keywords

chronic thromboembolic pulmonary hypertension; pulmonary hypertension

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; SILDENAFIL; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PIPERAZINE DERIVATIVE; PRO-BRAIN NATRIURETIC PEPTIDE (1-76); PURINE DERIVATIVE; SULFONE; VASODILATOR AGENT;

ADULT; ARTERY COMPLIANCE; ARTERY DIAMETER; ARTICLE; CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART CATHETERIZATION; HEART FUNCTION; HEART HEMODYNAMICS; HUMAN; LUNG ARTERY PRESSURE; MALE; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; WALKING; AGED; BLOOD; CHRONIC DISEASE; COMPLICATION; CONVALESCENCE; HEART; HEMODYNAMICS; HYPERTENSION, PULMONARY; MIDDLE AGED; PATHOPHYSIOLOGY; PULMONARY ARTERY; SINGLE BLIND PROCEDURE; THROMBOEMBOLISM; TIME;

ADULT; AGED; CHRONIC DISEASE; FEMALE; HEART; HEART CATHETERIZATION; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PIPERAZINES; PULMONARY ARTERY; PURINES; RECOVERY OF FUNCTION; SENSITIVITY AND SPECIFICITY; SINGLE-BLIND METHOD; SULFONES; THROMBOEMBOLISM; TIME FACTORS; TREATMENT OUTCOME; VASODILATOR AGENTS; WALKING; CARDIAC CATHETERIZATION;

EID: 77952542555     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2009.12.014     Document Type: Article

References (27)

1. Hoeper M.M., Mayer E., Simonneau G., et al. Chronic thromboembolic pulmonary hypertension. Circulation 113 (2006) 2011-2020
2. Riedel M., Stanek V., Widimsky J., et al. Longterm follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data. Chest 81 (1982) 151-158
3. Suntharalingam J., Treacy C.M., Doughty N.J., et al. Long term use of sildenafil in inoperable chronic thromboembolic pulmonary hypertension. Chest 134 (2008) 229-236
4. Jais X., D'Armini A.M., Jansa P., et al. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial. J Am Coll Cardiol 52 (2008) 2127-2134
5. Hughes R., Jais X., Suntharalingam J., et al. Current understanding of the role of bosentan in inoperable chronic thromboembolic pulmonary hypertension. Expert Opin Pharmacother 7 (2006) 1133-1138
6. Hoeper M.M., Kramm T., Wilkens H., et al. Bosentan therapy for inoperable chronic thromboembolic pulmonary hypertension. Chest 128 (2005) 2363-2367
7. Olschewski H., Simonneau G., Galie N., et al. Inhaled iloprost for severe pulmonary hypertension. N Engl J Med 347 (2002) 322-329
8. Ghofrani H.A., Schermuly R.T., Rose F., et al. Sildenafil for long-term treatment of nonoperable chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med 167 (2003) 1139-1141
9. Nagaya N., Shimizu Y., Satoh T., et al. Oral beraprost sodium improves exercise capacity and ventilatory efficiency in patients with primary or thromboembolic pulmonary hypertension. Heart 87 (2002) 340-345
10. Suntharalingam J., Hughes R.J., Goldsmith K., et al. Acute haemodynamic responses to inhaled nitric oxide and intravenous sildenafil in distal chronic thromboembolic pulmonary hypertension (CTEPH). Vasc Pharmacol 46 (2007) 449-455
11. Ulrich S., Fischler M., Speich R., et al. Chronic thromboembolic and pulmonary arterial hypertension share acute vasoreactivity properties. Chest 130 (2006) 841-846
12. Dinh-Xuan A.T., Pepke-Zaba J., Cremona G., et al. Endothelial dysfunction in vascular disease. Lancet 336 (1990) 1253
13. Dinh Xuan A.T., Higenbottam T.W., Clelland C., et al. Impairment of pulmonary endothelium-dependent relaxation in patients with Eisenmenger's syndrome. Br J Pharmacol 99 (1990) 9-10
14. Jardim C., Rochitte C.E., Humbert M., et al. Pulmonary artery distensibility in pulmonary arterial hypertension: an MRI pilot study. Eur Respir J 29 (2007) 476-481
15. Gan C.T., Lankhaar J.W., Westerhof N., et al. Noninvasively assessed pulmonary artery stiffness predicts mortality in pulmonary arterial hypertension. Chest 132 (2007) 1906-1912
16. Pasierski T.J., Starling R.C., Binkley P.F., et al. Echocardiographic evaluation of pulmonary artery distensibility. Chest 103 (1993) 1080-1083
17. Simonneau G., Galie N., Rubin L.J., et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 43 suppl S (2004) 5S-12
18. Klepetko W., Mayer E., Sandoval J., et al. Interventional and surgical modalities of treatment for pulmonary arterial hypertension. J Am Coll Cardiol 43 suppl S (2004) 73S-80
19. Stevens G.R., Lala A., Sanz J., et al. Exercise performance in patients with pulmonary hypertension linked to cardiac magnetic resonance measures. J Heart Lung Transplant 28 (2009) 899-905
20. Sanz J., Kariisa M., Dellegrottaglie S., et al. Evaluation of pulmonary artery stiffness in pulmonary hypertension with cardiac magnetic resonance. J Am Coll Cardiol Cardiovasc Imag 2 (2009) 286-295
21. Condliffe R., Kiely D.G., Gibbs J.S., et al. Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med 177 (2008) 1122-1127
22. Blyth K.G., Groenning B.A., Mark P.B., et al. NT-proBNP can be used to detect right ventricular systolic dysfunction in pulmonary hypertension. Eur Respir J 29 (2007) 737-744
23. Gan C.T., McCann G.P., Marcus J.T., et al. NT-proBNP reflects right ventricular structure and function in pulmonary hypertension. Eur Respir J 28 (2006) 1190-1194
24. Reeves J.T., Groves B.M., Turkevich D., et al. Right ventricular function in pulmonary hypertension. In: Weir K., and Reeves J.T. (Eds). Pulmonary vascular physiology and pathophysiology (1989), Marcel Dekker, New York 325-345
25. Wauthy P., Pagnamenta A., Vassalli F., et al. Right ventricular adaptation to pulmonary hypertension: an interspecies comparison. Am J Physiol Heart Circ Physiol 286 (2004) H1441-H1447
26. Lankhaar J.W., Westerhof N., Faes T.J., et al. Pulmonary vascular resistance and compliance stay inversely related during treatment of pulmonary hypertension. Eur Heart J 29 (2008) 1688-1695
27. Mahapatra S., Nishimura R.A., Oh J.K., et al. The prognostic value of pulmonary vascular capacitance determined by Doppler echocardiography in patients with pulmonary arterial hypertension. J Am Soc Echocardiogr 19 (2006) 1045-1050